AH
Andreas Halvorsen (Viking Global) disclosed new in DAMORA THERAPEUTICS INC
Andreas Halvorsen (Viking Global) filed a 13F change in DAMORA THERAPEUTICS INC (36322Q206) on 2026-05-15, covering period end 2026-03-31.
Action
New
Capital
$59,857,024 reported value
Institutional 13F Signals1 evidence source
Why it matters
This signal is anchored to the SEC filing date while retaining the underlying 13F period end.